<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
NVTA
Invitae
$
()


  • Invitae enters into agreement with Labcorp for $239M sale of business

    4/24/2024 - 21:24pm
  • Two option delistings on February 16th

    2/16/2024 - 08:30am
  • Invitae files for Chapter 11 protection, pursues sale process

    2/14/2024 - 05:35am
  • NYSE to commence delisting proceedings against Invitae

    2/6/2024 - 09:16am
  • Invitae trading halted, news dissemination

    2/6/2024 - 09:03am
  • Largest borrow rate increases among liquid names

    2/6/2024 - 08:45am
  • Invitae trading halted, news pending

    2/5/2024 - 14:42pm
  • Invitae down 9% after WSJ report on bankruptcy plans

    2/5/2024 - 11:14am
  • Invitae working with advisors to prepare for bankruptcy, WSJ reports

    2/5/2024 - 11:14am
  • Invitae partners with BridgeBio for discovery of rare disease therapeutics

    1/30/2024 - 07:06am
  • Invitae expects $4M in charges in Q1 from workforce reduction

    1/24/2024 - 16:42pm
  • Invitae completes sale of reproductive health assets to Natera

    1/22/2024 - 07:05am
  • Natera acquires reproductive health assets from Invitae

    1/22/2024 - 07:03am
  • Largest borrow rate increases among liquid names

    1/19/2024 - 08:45am
  • Natera price target raised to $64 from $56 at Goldman Sachs

    12/29/2023 - 06:08am
dynamic_feed Breaking News